Formation Venture Engineering — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
NonExomics is a drug discovery company that uses a machine learning platform integrating genomics, transcriptomics, and proteomics to identify novel "noncanonical" proteins encoded across the entire human genome, including the previously unstudied 98% "dark genome." It has cataloged hundreds of thousands of such proteins and thousands of novel druggable targets associated with over 1,300 human diseases for therapeutic development.
AI & Machine LearningBiotechDeep TechHealthtechActon, US
Ruchi Chauhan(Director)
Co-investorsIllumina Accelerator
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.